Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Enovix Corporation (ENVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Enovix Corporation — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.32 (market cap $4.59B), while Enovix Corporation trades at $2.46 (market cap $549.72M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 8.3× Enovix Corporation's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Enovix Corporation for 11 Days on average.
| DFTX | ENVX | |
|---|---|---|
Market Cap | $4.59B | $549.72M |
Volume | 2,103,937 | 6,635,687 |
Sector | Health | Industrials |
52-Week High | $48.45 | $13.19 |
52-Week Low | $10.68 | $2.50 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $3.55B | $611.42M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVX trades at $2.46, down 3.53% on the day, reflecting a bearish technical trend. The company is in a high-growth investment phase, with revenue growing to $36 million in 2026 but reporting significant losses. Recent news highlights a CEO transition and progress in battery manufacturing for defense and consumer electronics, while analyst consensus remains largely positive with a $10.75 price target.
The outlook is bifurcated: strong analyst buy ratings and institutional interest signal long-term potential, but high cash burn, persistent losses, and bearish technical indicators present substantial near-term risks. Investment hinges on successful commercialization and achieving profitability from current expansion efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →
